Detalhe da pesquisa
1.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599221
2.
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
J Am Coll Cardiol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819334
3.
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.
Nat Med
; 29(9): 2358-2365, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635157
4.
Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study.
J Clin Endocrinol Metab
; 104(5): 1725-1734, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30517746